Literature DB >> 19361701

[Double trypanosomal chancre revealing West African trypanosomiasis in a Frenchman living in Gabon].

E Hope-Rapp1, O Moussa Coulibaly, E Klement, M Danis, F Bricaire, E Caumes.   

Abstract

BACKGROUND: Human African trypanosomiasis (sleeping sickness), an endemic disease, is currently reemerging in Africa with an estimated incidence of 45,000 new cases per year. It is caused by Trypanosoma brucei subspecies and transmitted by day-biting tsetse flies. PATIENTS AND METHODS: We report a case of West African trypanosomiasis due to Trypanosoma brucei gambiense involving a Frenchman living in Libreville, Gabon. The patient presented with fever and polyadenopathies as well as two skin ulcerations highly suggestive of trypanosomiasis. Microscopic examination of cutaneous and peripheral blood smears confirmed the diagnosis of haemolymphatic infection with T. b. gambiense with trypanosomal chancres. Examination of the cerebrospinal fluid was normal. The patient was successfully treated with pentamidine isethionate.
CONCLUSIONS: Recognition of cutaneous manifestations may allow a rapid diagnosis of African trypanosomiasis that is essential for timely and efficient treatment and survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361701     DOI: 10.1016/j.annder.2008.09.023

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  3 in total

1.  Urban transmission of human African trypanosomiasis, Gabon.

Authors:  Fabrice Simon; Marie Mura; Frédéric Pagès; Gabriel Morand; Philippe Truc; Francis Louis; Philippe Gautret
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

2.  Dermatologic presentations of tropical diseases in travelers.

Authors:  Gentiane Monsel; Eric Caumes
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.663

3.  Outcome of acute East African trypanosomiasis in a Polish traveller treated with pentamidine.

Authors:  Małgorzata Paul; Jerzy Stefaniak; Piotr Smuszkiewicz; Marjan Van Esbroeck; Dirk Geysen; Jan Clerinx
Journal:  BMC Infect Dis       Date:  2014-02-27       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.